Valuation multiples, financial metrics, and company listings for the Materials sector.
P25: 15.5 / P75: 34.9
P25: 1.3 / P75: 6.2
P25: 8.8 / P75: 20.3
P25: -41.0% / P75: 14.7%
| Ticker | Name | Market Cap |
|---|---|---|
| LLY | ELI LILLY AND COMPANY | $824.1B |
Data updated daily · Source: SEC EDGAR, Polygon.io
| JNJ | Johnson & Johnson | $578.3B |
| ABBV | AbbVie Inc. | $371.9B |
| PG | PROCTER & GAMBLE CO | $335.5B |
| MRK | Merck & Co., Inc. | $296.3B |
| LIN | Linde plc | $231.5B |
| AMGN | AMGEN INC | $189.2B |
| ABT | Abbott Laboratories | $175.6B |
| GILD | GILEAD SCIENCES, INC. | $174.3B |
| PFE | PFIZER INC | $154.2B |
| BMY | BRISTOL-MYERS SQUIBB COMPANY | $118.6B |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $113.0B |
| REGN | REGENERON PHARMACEUTICALS, INC. | $79.9B |
| ECL | ECOLAB INC. | $77.1B |
| CL | COLGATE-PALMOLIVE COMPANY | $67.5B |
| APD | AIR PRODUCTS AND CHEMICALS, INC. | $66.0B |
| ZTS | Zoetis Inc. | $50.9B |
| IDXX | IDEXX LABORATORIES INC /DE | $46.4B |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $45.3B |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | $37.0B |
| KVUE | Kenvue Inc. | $33.4B |
| INSM | INSMED INCORPORATED | $33.1B |
| KMB | KIMBERLY-CLARK CORPORATION | $32.2B |
| DOW | Dow Inc. | $28.2B |
| EL | Estee Lauder Companies Inc | $27.6B |
| BIIB | BIOGEN INC. | $26.3B |
| UTHR | United Therapeutics Corporation | $25.4B |
| PPG | PPG INDUSTRIES, INC. | $24.7B |
| LYB | LyondellBasell Industries N.V. | $23.6B |
| CHD | CHURCH & DWIGHT CO., INC. | $22.6B |
| ALB | ALBEMARLE CORPORATION | $22.4B |
| SW | Smurfit Westrock plc | $22.1B |
| MRNA | Moderna, Inc. | $21.0B |
| IP | INTERNATIONAL PAPER COMPANY | $19.3B |
| DD | DUPONT DE NEMOURS, INC. | $19.1B |
| PKG | PACKAGING CORP OF AMERICA | $18.7B |
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | $18.5B |
| CF | CF Industries Holdings, Inc. | $18.3B |
| VTRS | VIATRIS INC. | $16.2B |
| WLK | Westlake Corporation | $15.1B |
| RPM | RPM International Inc. | $13.9B |
| AVY | AVERY DENNISON CORPORATION | $13.1B |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | $13.1B |
| SOLS | Solstice Advanced Materials Inc. | $12.7B |
| IONS | IONIS PHARMACEUTICALS, INC. | $12.7B |
| CLX | THE CLOROX COMPANY | $12.6B |
| JAZZ | Jazz Pharmaceuticals plc | $12.4B |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | $12.0B |
| EXEL | EXELIXIS, INC. | $11.9B |
| BMRN | BioMarin Pharmaceutical Inc | $10.7B |